Literature DB >> 17590105

[Hepatic stellate cells and oxidative stress].

R Urtasun1, N Nieto.   

Abstract

Hepatic fibrosis is a wound-healing response that takes place during chronic liver injury and is characterized by excessive production and deposition of extracellular matrix (ECM) components, mainly collagen type I. Hepatic stellate cells (HSC) are responsible for the excessive production of scar tissue during liver fibrosis. Activation of HSC, the main step in the development of hepatic fibrosis, is mediated by cytokines and reactive oxygen species (ROS) released by damaged hepatocytes and/or activated Kupffer cells and even HSC themselves. While HSC usually remain quiescent, in response to factors promoting liver injury they undergo activation and become highly proliferative and fibrogenic. Indeed a key feature of HSC activation is uncontrolled production of collagen type I. Collagen is a heterotrimeric protein composed of two a1 chains and one a2 chain forming a triple helix structure. Initiation of HSC activation is largely due to paracrine stimulation, whereas the perpetuation of such activated state involves autocrine as well as paracrine loops. This review focuses on the role of oxidant stress on the activation of stellate cells.

Entities:  

Mesh:

Year:  2007        PMID: 17590105     DOI: 10.4321/s1130-01082007000400007

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN: 1130-0108            Impact factor:   2.086


  7 in total

1.  Beneficial effects of fluvastatin on liver microcirculation and regeneration after massive hepatectomy in rats.

Authors:  Takuya Tokunaga; Toru Ikegami; Tomoharu Yoshizumi; Satoru Imura; Yuji Morine; Hisamitsu Shinohara; Mitsuo Shimada
Journal:  Dig Dis Sci       Date:  2008-03-25       Impact factor: 3.199

2.  Copper ions stimulate the proliferation of hepatic stellate cells via oxygen stress in vitro.

Authors:  San-Qing Xu; Hui-Yun Zhu; Jian-Guo Lin; Tang-Feng Su; Yan Liu; Xiao-Ping Luo
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-02-08

3.  Hexa Histidine-Tagged Recombinant Human Cytoglobin Deactivates Hepatic Stellate Cells and Inhibits Liver Fibrosis by Scavenging Reactive Oxygen Species.

Authors:  Ninh Quoc Dat; Le Thi Thanh Thuy; Vu Ngoc Hieu; Hoang Hai; Dinh Viet Hoang; Nguyen Thi Thanh Hai; Tuong Thi Van Thuy; Tohru Komiya; Krista Rombouts; Minh Phuong Dong; Ngo Vinh Hanh; Truong Huu Hoang; Misako Sato-Matsubara; Atsuko Daikoku; Chiho Kadono; Daisuke Oikawa; Katsutoshi Yoshizato; Fuminori Tokunaga; Massimo Pinzani; Norifumi Kawada
Journal:  Hepatology       Date:  2021-05-22       Impact factor: 17.425

Review 4.  4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine-recommendations for facing obesity, fatty liver and fibrosis epidemics.

Authors:  Francesca Maria Trovato; Daniela Catalano; Giuseppe Musumeci; Guglielmo M Trovato
Journal:  EPMA J       Date:  2014-12-07       Impact factor: 6.543

5.  The Identification of Core Gene Expression Signature in Hepatocellular Carcinoma.

Authors:  Ning Li; Ling Li; Yongshun Chen
Journal:  Oxid Med Cell Longev       Date:  2018-05-27       Impact factor: 6.543

6.  Specific siRNA targeting the receptor for advanced glycation end products inhibits experimental hepatic fibrosis in rats.

Authors:  Jin-Rong Xia; Nai-Feng Liu; Nai-Xun Zhu
Journal:  Int J Mol Sci       Date:  2008-04-24       Impact factor: 6.208

Review 7.  The Role of Autophagy and NLRP3 Inflammasome in Liver Fibrosis.

Authors:  Ye Tao; Ningning Wang; Tianming Qiu; Xiance Sun
Journal:  Biomed Res Int       Date:  2020-07-11       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.